We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002311:SZSEGuangdong Haid Group Co., Limited Analysis

Data as of 2026-03-17 - not real-time

CN¥57.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Guangdong Haid Group (002311.SZ) is trading at CNY 57.32, well above its DCF‑derived fair value of CNY 4.33, implying a substantial overvaluation despite a 21.7% upside estimate from the model. The stock shows a bullish technical backdrop—MACD histogram positive, RSI at 64, and price above both the 20‑day (54.54) and 50‑day (53.64) SMAs—yet it sits near the resistance level of 57.86 and the 200‑day SMA (57.56), suggesting limited short‑term upside. Volume is on an increasing trend, supporting liquidity, while volatility remains high at ~29% over the past 30 days.
Fundamentally, the company delivers solid top‑line growth (14.4% YoY revenue expansion) and strong profitability metrics (ROE 21%, operating margin 5%). Dividend sustainability appears robust with a 2.25% yield, a 43% payout ratio, and healthy cash flows, but the high P/E (19×) and P/B (3.79×) reinforce the overvalued assessment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance and 200‑day SMA limiting upside
  • Bullish MACD but elevated RSI indicating potential overbought condition
  • Increasing volume supporting current price stability

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and ROE suggesting underlying business strength
  • Persistent overvaluation relative to DCF and fair‑value metrics
  • Stable dividend yield and payout ratio enhancing cash‑flow appeal

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Defensive consumer sector positioning with resilient demand for animal feed
  • Sustainable dividend and solid cash generation for shareholder returns
  • Potential price correction aligning market price closer to intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin3.99%
P/E Ratio19.0
ROE21.00%
ROA7.97%
Debt/Equity15.84
P/B Ratio3.8
Op. Cash FlowCN¥5.2B
Free Cash FlowCN¥175.0M

Technical Analysis

TrendNeutral
RSI64.2
SupportCN¥52.61
ResistanceCN¥57.86
MA 20CN¥54.54
MA 50CN¥53.64
MA 200CN¥57.56
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair ValueCN¥4.33
Target PriceCN¥69.73
Upside/Downside21.66%
GradeOvervalued
TypeBlend
Dividend Yield2.25%

Risk Assessment

Beta-0.11
Volatility29.45%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.